"Dopamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
Descriptor ID |
D004298
|
MeSH Number(s) |
D02.092.211.215.311.342 D02.092.311.342
|
Concept/Terms |
Dopamine- Dopamine
- 4-(2-Aminoethyl)-1,2-benzenediol
- Hydroxytyramine
- 3,4-Dihydroxyphenethylamine
- 3,4 Dihydroxyphenethylamine
|
Below are MeSH descriptors whose meaning is more general than "Dopamine".
Below are MeSH descriptors whose meaning is more specific than "Dopamine".
This graph shows the total number of publications written about "Dopamine" by people in this website by year, and whether "Dopamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 3 | 6 |
1995 | 2 | 1 | 3 |
1996 | 0 | 3 | 3 |
1997 | 2 | 0 | 2 |
1998 | 3 | 0 | 3 |
1999 | 3 | 1 | 4 |
2000 | 1 | 4 | 5 |
2001 | 5 | 1 | 6 |
2002 | 5 | 4 | 9 |
2003 | 1 | 2 | 3 |
2004 | 8 | 1 | 9 |
2005 | 7 | 2 | 9 |
2006 | 4 | 7 | 11 |
2007 | 7 | 6 | 13 |
2008 | 3 | 3 | 6 |
2009 | 5 | 5 | 10 |
2010 | 5 | 2 | 7 |
2011 | 10 | 3 | 13 |
2012 | 3 | 1 | 4 |
2013 | 4 | 4 | 8 |
2014 | 3 | 5 | 8 |
2015 | 3 | 2 | 5 |
2016 | 2 | 3 | 5 |
2017 | 3 | 2 | 5 |
2018 | 4 | 3 | 7 |
2019 | 3 | 2 | 5 |
2020 | 4 | 1 | 5 |
2021 | 4 | 2 | 6 |
2022 | 0 | 2 | 2 |
2023 | 1 | 2 | 3 |
2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine" by people in Profiles.
-
Murillo Gonzalez DJ, Hernandez Granados BA, Sabandal PR, Han KA. Social setting interacts with hyper dopamine to boost the stimulant effect of ethanol. Addict Biol. 2024 06; 29(6):e13420.
-
Du Y, Li Q, Zhou G, Cai Z, Man Q, Wang WC. Early-life perfluorooctanoic acid exposure disrupts the function of dopamine transporter protein with glycosylation changes implicating the links between decreased dopamine levels and disruptive behaviors in larval zebrafish. Sci Total Environ. 2024 Mar 20; 917:170408.
-
Luj?n M?, Covey DP, Young-Morrison R, Zhang L, Kim A, Morgado F, Patel S, Bass CE, Paladini C, Cheer JF. Mobilization of endocannabinoids by midbrain dopamine neurons is required for the encoding of reward prediction. Nat Commun. 2023 Nov 20; 14(1):7545.
-
Fernandez RF, Wilson ES, Diaz V, Mart?nez-Gardeazabal J, Foguth R, Cannon JR, Jackson SN, Hermann BP, Eells JB, Ellis JM. Lipid metabolism in dopaminergic neurons influences light entrainment. J Neurochem. 2023 05; 165(3):379-390.
-
Kim S, Pajarillo E, Nyarko-Danquah I, Aschner M, Lee E. Role of Astrocytes in Parkinson's Disease Associated with Genetic Mutations and Neurotoxicants. Cells. 2023 02 15; 12(4).
-
Getachew B, Csoka AB, Copeland RL, Manaye KF, Tizabi Y. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease. Neurotox Res. 2023 Apr; 41(2):141-148.
-
El Hayek SA, Shatila MA, Adnan JA, Geagea LE, Kobeissy F, Talih FR. Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia? Expert Rev Neurother. 2022 Sep; 22(9):737-749.
-
Baker RP, Chrissian C, Stark RE, Casadevall A. Cryptococcus neoformans melanization incorporates multiple catecholamines to produce polytypic melanin. J Biol Chem. 2022 01; 298(1):101519.
-
Opendak M, Raineki C, Perry RE, Rinc?n-Cort?s M, Song SC, Zanca RM, Wood E, Packard K, Hu S, Woo J, Martinez K, Vinod KY, Brown RW, Deehan GA, Froemke RC, Serrano PA, Wilson DA, Sullivan RM. Bidirectional control of infant rat social behavior via dopaminergic innervation of the basolateral amygdala. Neuron. 2021 12 15; 109(24):4018-4035.e7.
-
Malave L, Zuelke DR, Uribe-Cano S, Starikov L, Rebholz H, Friedman E, Qin C, Li Q, Bezard E, Kottmann AH. Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson's disease and L-Dopa induced dyskinesia. Commun Biol. 2021 09 22; 4(1):1071.